CRISPR Cas9 is a genome editing technique that uses the Cas9 enzyme to cut DNA at specific locations. In 2018, Dr. He Jiankui conducted the first human genome editing trial using CRISPR Cas9 to modify embryos' genes in an attempt to make them resistant to HIV. This resulted in the birth of twin girls known as "Nana" and "Lulu". However, Dr. He's experiment was highly controversial and considered unethical due to safety risks. While genome editing holds promise for treating disease, more research is needed to address ethical concerns before making heritable genetic changes.